Results 11 to 20 of about 261,124 (307)

Stroke, Thrombosis, Bleeding and Addiction to Anticoagulants in the Context of Course Therapy: A Pharmacologic Perspective

Reviews in Cardiovascular Medicine, 2022
After reading with great interest the article entitled: “Non-vitamin K antagonist oral anticoagulants (NOACs) do not increase the risk of hepatic impairment in patients with non-valvular atrial fibrillation: insights from multi-source medical data ...
Aleksandr Urakov, Anastasia Stolyarenko, Ilnur Yagudin, Nikita Mukhutdinov, Ilnur Bashirov   +4 more
doaj   +1 more source

Factor XI as a Target for New Anticoagulants

Hämostaseologie, 2021
Despite advances in anticoagulant therapy, thrombosis remains the leading cause of morbidity and mortality worldwide. Heparin and vitamin K antagonists (VKAs), the first anticoagulants to be used successfully for the prevention and treatment of ...
J. Fredenburgh, J. Weitz
semanticscholar   +1 more source

Efficacy and safety of non-vitamin K antagonist oral anticoagulants for venous thromboembolism: a meta-analysis

JRSM Open, 2021
Objective Several trials had compared the efficacy and safety between non-vitamin K antagonist oral anticoagulants and warfarin for acute venous thromboembolism, but the results were incomplete.
Yan Zhuang, Lin-feng Dai, Ming-qi Chen
doaj   +1 more source

The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF)

Annals of Medicine, 2022
Background Literature suggests that different risks of mortality could influence physicians in prescribing or not anticoagulants in older patients with atrial fibrillation (AF). The Multidimensional Prognostic Index (MPI) can be considered a tool for the
Alberto Pilotto, Nicola Veronese, Maria Cristina Polidori, Timo Strandberg, Eva Topinkova, Alfonso J. Cruz-Jentoft, Carlo Custodero, Stefania Maggi   +7 more
doaj   +1 more source

How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia

Journal of Pharmaceutical Policy and Practice, 2021
Background Anticoagulants are the cornerstone therapy for the management of venous thromboembolism (VTE) and atrial fibrillation (AF). Pharmacists should be confident and equipped with the skill and updated knowledge in managing anticoagulation therapy ...
Sze Ling Tan, Zai Yang Yong, Jerry Ee Siung Liew, Hadzliana Zainal, Sania Siddiqui   +4 more
doaj   +1 more source

Antiviral anticoagulation [PDF]

Research and Practice in Thrombosis and Haemostasis, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel envelope virus that causes coronavirus disease 2019 (COVID-19). Hallmarks of COVID-19 are a puzzling form of thrombophilia that has elevated D-dimer but only modest effects on other parameters of coagulopathy.
Pryzdial, Edward L. G., Sutherland, Michael R., Lin, Bryan H., Horwitz, Marc   +3 more
openaire   +3 more sources

Brainstem stroke in a Nigerian male with prosthetic heart valves—A case report

International Journal of Medicine and Health Development, 2022
Stroke following cardiac surgery particularly valvular implantation is an anticipated complication. This is due to the prosthetic valve as well as possible associated comorbid conditions. There is dearth of published data on stroke post valve replacement
Ralph C Anakwue, Ikenna O Onwuekwe, Rhoda C Nwutobo, Chinwendu J Onwuekwe   +3 more
doaj   +1 more source

Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death

Research and Practice in Thrombosis and Haemostasis, 2022
Background Risks of antithrombotic switching is not investigated in elderly atrial fibrillation patients. Objectives To investigate the effectiveness and safety of antithrombotic treatment and switching of antithrombotic treatment in elderly patients ...
Hanne Ehrlinder, Nicola Orsini, Karin Modig, Håkan Wallén, Bruna Gigante   +4 more
doaj   +1 more source

Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis, 2020
Clarity and guidance is required with regard to the use of direct oral anticoagulants in antiphospholipid syndrome (APS) patients, within the confines of the recent European Medicines Agency recommendations, discrepant recommendations in other ...
S. Zuily, H. Cohen, D. Isenberg, S. Woller, M. Crowther, V. Dufrost, D. Wahl, C. Doré, A. Cuker, M. Carrier, V. Pengo, K. Devreese   +11 more
semanticscholar   +1 more source

Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban‐treated patients and healthy controls

Research and Practice in Thrombosis and Haemostasis, 2022
Introduction The activated partial thromboplastin time (aPTT) and the prothrombin time (PT) are widely available coagulation parameters which are however poor predictors of the anticoagulant effect of direct oral anticoagulants (DOACs).
Jonathan Evrard, Romain Siriez, Céline Bouvy, Julien Favresse, Halil Yildiz, Philippe Hainaut, François Mullier, Jean‐Michel Dogné, Jonathan Douxfils   +8 more
doaj   +1 more source